Abstract:Due to the complexity and variability of the cellular metabolic process and the physiological environment inside and outside the cell, higher requirements are needed on the application of DNA molecular logic gate in cell analysis. In addition, heterogeneity of tumor cells tends to lead to false positives in the clinical diagnosis of a single target, even those with the same cancer type. To address these issues above, we have developed a novel DNA molecular logic gate responsive nanomachine for bispecific recognition and computation of cell membranes. Only when two membrane proteins, MUC1 and EpCAM as model proteins, exist simultaneously, the DNA molecular logic gate can be activated to perform "AND" logic operation and generate amplified "ON" fluorescence signal from the cell membrane. Therefore, our proposed dual-specific "recognition-biocomputing" DNA molecular logic gate has achieved highly accurate imaging analysis of dual-target membrane proteins in situ. Furthermore, the logic gate responsive DNA nanomachine can also be used to analyze target cells in complex cell samples with excellent specificity, which will meet the needs of biomedicine and their application in clinical diagnosis and provide new tools for the biomedical application of DNA molecular logic gates in complex cell systems.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acssensors.0c01166?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acssensors.0c01166</a>.Sequences of DNA oligonucleotides used in this work (Table S1). Schematic diagram of the digestion of PA1 by phi29 DNA polymerase and digestion of 1 μM PA1 by phi29 DNA polymerase for 0–60 min (Figure S1). Schematic diagram of the digestion of PA1-CT by phi29 DNA polymerase and digestion of 1 μM PA1 by phi29 DNA polymerase in the presence of 0–2.5 μM CT (Figure S2). Immunofluorescence of mucin (MUC1) from three cell lines and immunofluorescence of epithelial adhesion molecules (EpCAM) from three cell lines. Scale bar = 20 μm (Figure S3). Western blotting results of MUC1 and EpCAM expression from three cell lines (Figure S4). Fluorescence microscopy images of MCF-7 cells incubated in DNA nanomachine for different times (0–90 min). Scale bar = 20 μm (Figure S5). Fluorescence microscopy images and fluorescence intensity statistics of different rolling circle amplification times after the interaction of DNA nanomachine with the cell membrane surface. Scale bar = 20 μm (Figure S6). Schematic diagram of fluorophore-labeled DNA ternary complex, fluorescence intensity analysis of assembly of fluorophore-labeled DNA ternary complex, and confocal laser scanning microscopy images of three cell lines incubated with fluorophore-labeled DNA nanomachine. Scale bar = 20 μm (Figure S7). Study on the amplification efficiency of logic gate responsive DNA nanomachine. Confocal laser scanning microscopy images of MCF-7 cells incubated with different DNA assemblies: (A) green fluorescence (FAM) and (B) red fluorescence (Cy5). (C, D) Fluorescence intensity statistics of cell imaging from (A) and (B) by ImageJ software. Scale bar = 20 μm (Figure S8) (<a class="ext-link" href="/doi/suppl/10.1021/acssensors.0c01166/suppl_file/se0c01166_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

A dual-biomarker-controlled DNA logic platform assisted with multivariate statistical analysis for accurate and high-throughput recognition of cancer cells

Programmable and Multiparameter DNA-based Logic Platform for Cancer Recognition and Targeted Therapy.

DNA Logic Circuits for Multiple Tumor Cells Identification Using Intracellular MicroRNA Molecular Bispecific Recognition

Dual-microRNA-controlled Double-Amplified Cascaded Logic DNA Circuits for Accurate Discrimination of Cell Subtypes.

Membrane Protein and Extracellular Acid Heterogeneity-Driven Amplified DNA Logic Gate Enables Accurate and Sensitive Identification of Cancer Cells

Multifunctional dumbbell probes-based logic circuits: microRNAs logic detection and tumor cells identification

Construction of a Multiple-Aptamer-Based DNA Logic Device on Live Cell Membranes Via Associative Toehold Activation for Accurate Cancer Cell Identification

A DNA Logic Circuit Equipped with a Biological Amplifier Loaded into Biomimetic ZIF‐8 Nanoparticles Enables Accurate Identification of Specific Cancers in Vivo

DNA logic gate for cancer cells identification, detection, and modulation of cell–cell interactions

A high-integrated DNA biocomputing platform for MicroRNA sensing in living cells

The Compact Integration of a Cascaded HCR Circuit for Highly Reliable Cancer Cell Discrimination

A superior strategy for single-cell mutational screening via multiplex-targeted QPCR using the BioMark HD microfluidic platform.

DNA hairpin self-assembly on cell membrane triggered by Dual-aptamer logic circuit for cancer cell recognition and photodynamic therapy

Logic Signal Amplification System for Sensitive Electrochemiluminescence Detection and Subtype Identification of Cancer Cells

DNA-framework-based multidimensional molecular classifiers for cancer diagnosis

Dual mature microRNA-responsive logic biosensing platform based on CRISPR/Cas12a and DNA nanocage

DNA Logical Computing on a Transistor for Cancer Molecular Diagnosis

Construction of a Ternary Complex Based DNA Logic Nanomachine for a Highly Accurate Imaging Analysis of Cancer Cells

DNA Logic Nanodevices for the Sequential Imaging of Cancer Markers Through Localized Catalytic Hairpin Assembly Reaction

Compute-and-Release Logic-Gated DNA Cascade Circuit for Accurate Cancer Cell Imaging

Dual-Locked DNAzyme Platform for In Vitro and In Vivo Discrimination of Cancer Cells